Cramer's Investing Club: Recent drop in a portfolio drug stock only a minor setback

We think Eli Lilly's recent pullback from recent highs gives investors a second chance to start or further add to positions.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.